drugset / Trial / NCT06109064
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
NaSingle-groupOpen-labelTreatment
Summary
This study aimed to evaluate the safety and efficacy of unrelated umbilical cord blood microtransplantation in the treatment of above-mentioned MDS patients by observing the factors related to the efficacy and adverse reactions.
Timeline
- Start
- 2023-10-27
- Primary completion
- 2024-02-01
- Completion
- 2026-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Unrelated Umbilical Cord Blood | Cell therapy | — | — |
| Background | Azacitidine | Other / unclassified | 75 mg/m2 | — |
| Background | Decetabine | Unknown | 20 mg/m2 | — |
| Background | Venetoclax | Small molecule | 400 mg | — |